不列颠哥伦比亚省阿片类受体激动剂治疗的每日配药和见证摄入所致增支：2014-20 年》的更正。

IF 5.2 1区医学 Q1 PSYCHIATRY Addiction Pub Date : 2024-03-18 DOI:10.1111/add.16489

{"title":"不列颠哥伦比亚省阿片类受体激动剂治疗的每日配药和见证摄入所致增支：2014-20 年》的更正。","authors":"","doi":"10.1111/add.16489","DOIUrl":null,"url":null,"abstract":"Nosyk B, Kurz M, Guerra-Alejos BC, Piske M, Dale L, Min JE. Incremental expenditures attributable to daily dispensation and witnessed ingestion for opioid agonist treatment in British Columbia: 2014–20. Addiction. 2023;118(7):1376–1380. https://doi.org/10.1111/add.16160In the “Acknowledgements” section, the text “This work was funded by a Health Canada Substance Use and Addictions Program grant no. 1819-HQ-000036. We would like to thank Patrick Day (Pharmaceuticals Analytics, Government of British Columbia) for his consultation and contributions to the conceptualization of this article. All inferences, opinions and conclusions drawn in this study are those of the authors and do not reflect the opinions or policies of the Data Steward(s).” was missing a funding source.This should have read: “This work was funded by a Health Canada Substance Use and Addictions Program (grant no. 1819-HQ-000036) and the National Institutes on Drug Abuse (NIDA grant no. R01DA050629). We would like to thank Patrick Day (Pharmaceuticals Analytics, Government of British Columbia) for his consultation and contributions to the conceptualization of this article. All inferences, opinions and conclusions drawn in this study are those of the authors and do not reflect the opinions or policies of the Data Steward(s).”We apologize for this error.","PeriodicalId":109,"journal":{"name":"Addiction","volume":"119 6","pages":"1143"},"PeriodicalIF":5.2000,"publicationDate":"2024-03-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/add.16489","citationCount":"0","resultStr":"{\"title\":\"Corrigendum to “Incremental expenditures attributable to daily dispensation and witnessed ingestion for opioid agonist treatment in British Columbia: 2014–20”\",\"authors\":\"\",\"doi\":\"10.1111/add.16489\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Nosyk B, Kurz M, Guerra-Alejos BC, Piske M, Dale L, Min JE. Incremental expenditures attributable to daily dispensation and witnessed ingestion for opioid agonist treatment in British Columbia: 2014–20. Addiction. 2023;118(7):1376–1380. https://doi.org/10.1111/add.16160In the “Acknowledgements” section, the text “This work was funded by a Health Canada Substance Use and Addictions Program grant no. 1819-HQ-000036. We would like to thank Patrick Day (Pharmaceuticals Analytics, Government of British Columbia) for his consultation and contributions to the conceptualization of this article. All inferences, opinions and conclusions drawn in this study are those of the authors and do not reflect the opinions or policies of the Data Steward(s).” was missing a funding source.This should have read: “This work was funded by a Health Canada Substance Use and Addictions Program (grant no. 1819-HQ-000036) and the National Institutes on Drug Abuse (NIDA grant no. R01DA050629). We would like to thank Patrick Day (Pharmaceuticals Analytics, Government of British Columbia) for his consultation and contributions to the conceptualization of this article. All inferences, opinions and conclusions drawn in this study are those of the authors and do not reflect the opinions or policies of the Data Steward(s).”We apologize for this error.\",\"PeriodicalId\":109,\"journal\":{\"name\":\"Addiction\",\"volume\":\"119 6\",\"pages\":\"1143\"},\"PeriodicalIF\":5.2000,\"publicationDate\":\"2024-03-18\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1111/add.16489\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Addiction\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1111/add.16489\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"PSYCHIATRY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Addiction","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/add.16489","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PSYCHIATRY","Score":null,"Total":0}

引用次数: 0

摘要

Nosyk B, Kurz M, Guerra-Alejos BC, Piske M, Dale L, Min JE.不列颠哥伦比亚省阿片类受体激动剂治疗的每日配药和目击摄入导致的增量支出：2014-20 年。Addiction.2023；118（7）：1376-1380。https://doi.org/10.1111/add.16160In "致谢 "部分的文字 "这项工作由加拿大卫生部物质使用和成瘾项目资助，编号为 1819-HQ-000036。我们要感谢 Patrick Day（不列颠哥伦比亚省政府药物分析部）为本文的构思提供的咨询和贡献。本研究中得出的所有推论、观点和结论均属作者个人观点，并不反映数据管理人的观点或政策"："这项工作得到了加拿大卫生部物质使用与成瘾项目（拨款号：1819-HQ-000036）和美国国家药物滥用研究所（拨款号：R01DA050629）的资助。我们要感谢 Patrick Day（不列颠哥伦比亚省政府制药分析部）为本文的构思提供的咨询和贡献。本研究中的所有推论、观点和结论均属作者个人观点，并不反映数据管理人的观点或政策。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

Corrigendum to “Incremental expenditures attributable to daily dispensation and witnessed ingestion for opioid agonist treatment in British Columbia: 2014–20”

Nosyk B, Kurz M, Guerra-Alejos BC, Piske M, Dale L, Min JE. Incremental expenditures attributable to daily dispensation and witnessed ingestion for opioid agonist treatment in British Columbia: 2014–20. Addiction. 2023;118(7):1376–1380. https://doi.org/10.1111/add.16160

In the “Acknowledgements” section, the text “This work was funded by a Health Canada Substance Use and Addictions Program grant no. 1819-HQ-000036. We would like to thank Patrick Day (Pharmaceuticals Analytics, Government of British Columbia) for his consultation and contributions to the conceptualization of this article. All inferences, opinions and conclusions drawn in this study are those of the authors and do not reflect the opinions or policies of the Data Steward(s).” was missing a funding source.

This should have read: “This work was funded by a Health Canada Substance Use and Addictions Program (grant no. 1819-HQ-000036) and the National Institutes on Drug Abuse (NIDA grant no. R01DA050629). We would like to thank Patrick Day (Pharmaceuticals Analytics, Government of British Columbia) for his consultation and contributions to the conceptualization of this article. All inferences, opinions and conclusions drawn in this study are those of the authors and do not reflect the opinions or policies of the Data Steward(s).”

We apologize for this error.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Addiction 医学-精神病学

CiteScore

10.80

自引率

6.70%

发文量

319

审稿时长

3 months

期刊介绍： Addiction publishes peer-reviewed research reports on pharmacological and behavioural addictions, bringing together research conducted within many different disciplines. Its goal is to serve international and interdisciplinary scientific and clinical communication, to strengthen links between science and policy, and to stimulate and enhance the quality of debate. We seek submissions that are not only technically competent but are also original and contain information or ideas of fresh interest to our international readership. We seek to serve low- and middle-income (LAMI) countries as well as more economically developed countries. Addiction’s scope spans human experimental, epidemiological, social science, historical, clinical and policy research relating to addiction, primarily but not exclusively in the areas of psychoactive substance use and/or gambling. In addition to original research, the journal features editorials, commentaries, reviews, letters, and book reviews.